Thousand Oaks Biopharmaceuticals Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
710
- Latest Deal Type
-
IPO
- (Cancelled)
- Investors
-
35
Thousand Oaks Biopharmaceuticals General Information
Description
Operator of a chemistry, manufacturing and controls (CMC) organization. The company offers contract development and manufacturing company (CDMO) services, enabling partners to provide accessible and affordable biologics for humanity.
Contact Information
Website
www.tobiopharm.comCorporate Office
- B1 Floor
- No. 100 Dongting Lake Road, Linjiang Town, Haimen District
- Nantong, Jiangsu
- China
Corporate Office
- B1 Floor
- No. 100 Dongting Lake Road, Linjiang Town, Haimen District
- Nantong, Jiangsu
- China
Thousand Oaks Biopharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. IPO | 26-Dec-2023 | Cancelled | Profitable | |||
| 11. Later Stage VC (Series D) | 28-Dec-2021 | Completed | Profitable | |||
| 10. Secondary Transaction - Private | 27-Aug-2021 | Completed | Profitable | |||
| 9. Later Stage VC | 24-Apr-2021 | Completed | Profitable | |||
| 8. Later Stage VC (Series C) | 10-Mar-2021 | Completed | Profitable | |||
| 7. Secondary Transaction - Private | 30-Sep-2020 | Completed | Generating Revenue | |||
| 6. Secondary Transaction - Private | 23-Jul-2020 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series B) | 23-Jul-2020 | Completed | Generating Revenue | |||
| 4. Secondary Transaction - Private | 22-May-2020 | $4.23M | $29.4M | Completed | Generating Revenue | |
| 3. Secondary Transaction - Private | 29-Jan-2019 | $18M | $29.4M | Completed | Generating Revenue |
Thousand Oaks Biopharmaceuticals Comparisons
Industry
Financing
Details
Thousand Oaks Biopharmaceuticals Competitors (15)
One of Thousand Oaks Biopharmaceuticals’s 15 competitors is Shanghai Medicilon, a Formerly VC-backed company based in Shanghai, China.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Shanghai Medicilon | Formerly VC-backed | Shanghai, China | ||||
| WuXi Biologics | Formerly VC-backed | Wuxi, China | ||||
| ChemPartner | Formerly PE-Backed | Shanghai, China | ||||
| WuXi AppTec | Formerly PE-Backed | Shanghai, China | ||||
| Giant Med-Pharma Services | Venture Capital-Backed | Beijing, China |
Thousand Oaks Biopharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Thousand Oaks Biopharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Thousand Oaks Biopharmaceuticals Investors (35)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| China Galaxy Securities | Corporation | Minority | ||
| Ciit Asset Management | Asset Manager | Minority | ||
| Cinda Capital Management | PE/Buyout | Minority | ||
| Golden Section IFA | VC-Backed Company | Minority | ||
| ICBC International | Investment Bank | Minority |
Thousand Oaks Biopharmaceuticals Investments (1)
Thousand Oaks Biopharmaceuticals’s most recent deal was a Joint Venture with Bioprocess Solution (Thousand Oaks Biopharmaceuticals / WSG Group). The deal was made on 27-Jan-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Bioprocess Solution (Thousand Oaks Biopharmaceuticals / WSG Group) | 27-Jan-2021 | Joint Venture | Other Pharmaceuticals and Biotechnology |
Thousand Oaks Biopharmaceuticals FAQs
-
When was Thousand Oaks Biopharmaceuticals founded?
Thousand Oaks Biopharmaceuticals was founded in 2017.
-
Where is Thousand Oaks Biopharmaceuticals headquartered?
Thousand Oaks Biopharmaceuticals is headquartered in Nantong, China.
-
What is the size of Thousand Oaks Biopharmaceuticals?
Thousand Oaks Biopharmaceuticals has 710 total employees.
-
What industry is Thousand Oaks Biopharmaceuticals in?
Thousand Oaks Biopharmaceuticals’s primary industry is Biotechnology.
-
Is Thousand Oaks Biopharmaceuticals a private or public company?
Thousand Oaks Biopharmaceuticals is a Private company.
-
What is Thousand Oaks Biopharmaceuticals’s current revenue?
The current revenue for Thousand Oaks Biopharmaceuticals is .
-
How much funding has Thousand Oaks Biopharmaceuticals raised over time?
Thousand Oaks Biopharmaceuticals has raised $395M.
-
Who are Thousand Oaks Biopharmaceuticals’s investors?
China Galaxy Securities, Ciit Asset Management, Cinda Capital Management, Golden Section IFA, and ICBC International are 5 of 35 investors who have invested in Thousand Oaks Biopharmaceuticals.
-
Who are Thousand Oaks Biopharmaceuticals’s competitors?
Shanghai Medicilon, WuXi Biologics, ChemPartner, WuXi AppTec, and Giant Med-Pharma Services are some of the 15 competitors of Thousand Oaks Biopharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
